.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advances in the Diagnosis and Treatment of BPDCN

EP. 1: Dr Taylor on the Integration of Tagraxofusp Into the Frontline Treatment Armamentarium for BPDCN

April 10th 2023

Justin W. Taylor, MD, discusses the evolution of frontline treatment options for patients with blastic plasmacytoid dendritic cell neoplasm, including the integration of tagraxofusp-erzs into the treatment armamentarium in this disease space.

EP. 2: Dr Mohammed on the Challenges of Diagnosing BPDCN

April 18th 2023

Turab J. Mohammed, MD, discusses challenges associated with the diagnosis of blastic plasmacytoid dendritic cell neoplasm, and strategies to improve early diagnosis of this disease.

EP. 3: Dr Venugopal on Challenges With the Diagnosis of BPDCN

April 25th 2023

Sangeetha Venugopal, MD, MS, discusses the importance of increasing awareness of blastic plasmacytoid dendritic cell neoplasm to improve early diagnosis and treatment for patients with BPDCN at academic centers.

EP. 4: Advances in the Diagnosis and Treatment of BPDCN

May 17th 2023